What's Happening?
The integration of artificial intelligence (AI) in healthcare is raising questions about governance and the involvement of clinical professionals, particularly pharmacists, in decision-making processes. At the HIMSS AI in Healthcare Forum, experts discussed
the need for mature data standards and stronger governance to manage AI effectively. Dan Eduardo Gonzalez, founder of ClarityRx Advisory, emphasized the importance of involving pharmacists early in AI development due to their expertise in medication safety and regulatory compliance. Current trends show that 86% of healthcare organizations are embedding AI into their operations, highlighting the need for governance frameworks that include clinical insights.
Why It's Important?
The involvement of pharmacists in AI governance is crucial as they bring valuable clinical insights that can influence patient care decisions. As healthcare organizations increasingly adopt AI, ensuring that governance frameworks reflect real-world clinical workflows is essential for patient safety and effective implementation. The exclusion of pharmacists from early AI development stages could lead to governance challenges and operational inefficiencies, impacting the quality of care and increasing costs. By integrating clinical expertise from the outset, healthcare organizations can better align technological advancements with patient care needs.
What's Next?
Healthcare organizations are likely to reevaluate their AI governance strategies to include clinical professionals earlier in the development process. This shift could lead to more effective collaboration between engineers, clinicians, and compliance professionals, reducing operational costs and improving patient outcomes. As AI continues to evolve, ongoing discussions about governance and clinical involvement will be necessary to address emerging challenges and ensure sustainable implementation.
